Article: Pharma company's long-term study of Celebrex expected to continue.

Article: NIH: No higher CV risk seen in ADAPT study with ...
Pharma Marketletter;  January 3, 2005 ;     655 words ...The US National Institutes of Health has reported ... s COX-2 inhibitor Celebrex (celecoxib; 400mg daily ... one of three studies of Celebrex demonstrated an increased ... However, while fears over Celebrex were allayed to some ...

Article: No Evidence of Cardiovascular Safety Signal for Pfizer's ...
PR Newswire;  October 1, 2004 ;     700+ words ... ... which are assessing Celebrex as a potential preventative ... Cancer Institute, the National Institutes of Health and Pfizer ... cardiovascular safety of Celebrex has accumulated over ... controlled study examining Celebrex's potential to prevent ... is sponsored by the National ...

Article: Pharma company's long-term study of Celebrex expected to ...
Heart Disease Weekly;  November 7, 2004 ;     700+ words ... ... which are assessing Celebrex as a potential preventative ... Institute, the U.S. National Institutes of Health and Pfizer ... cardiovascular safety of Celebrex has accumulated over ... controlled study examining Celebrex's potential to prevent ... sponsored by the U.S. National ...

Article: Cloud over Celebrex Study finds painkiller triples heart ...
The Sun, San Bernardino, Calif.;  December 18, 2004 ;     700+ words ... ... international study using Celebrex because long-term use of ... higher and lower doses of Celebrex. Within minutes of getting ... Zerhouni, director of the National Institutes of Health, said four dozen ... 2 inhibitors, including Celebrex, will now undergo the same ...

Transcript: Analysis: Update on the Celebrex controversy
NPR All Things Considered;  December 20, 2004 ;     700+ words ... ... pulled Vioxx from the market. Celebrex may be less risky than Vioxx ... or should have known about Celebrex's risks. Lawyers and investors ... help in seeing through the Celebrex fog. The FDA's acting ... Meanwhile, late today, the National Institutes of Health announced the suspension ...

Transcript: Analysis: Pfizer announces results of study showing patients ...
NPR All Things Considered;  December 17, 2004 ;     700+ words ... ... whether to keep patients on Celebrex. Mr. LESTER CRAWFORD ... lowest effective dose of Celebrex. KNOX: And the director of the National Institutes of Health says his agency ... Ray says that applies to Celebrex, too. Mr. WAYNE RAY ...

Article: STUDY QUESTIONS SAFETY OF CELEBREX IN TESTS, PFIZER FOUND ...
Wisconsin State Journal (Madison, WI);  December 18, 2004 ;     700+ words ... ... concern about this product (Celebrex) and the class of products ... depressant use in children. Both Celebrex and Vioxx are a type of drug ... strokes. Long-term trials National Institutes of Health director Dr. Elias ... heart risk for patients using Celebrex came in one of two long ...